ClinicalBiostats

07 · Therapeutic Area

Respiratory Clinical Trials

Asthma, COPD, pulmonary fibrosis and cystic fibrosis trials, including exacerbation-rate endpoints analyzed with negative binomial and Poisson models.

625 trials in this area

Statistical methods in respiratory trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

ANCOVA Used in 16% of respiratory trials · Analyzing Change from Baseline in Clinical Trials → Hazard ratio Used in 13% of respiratory trials · Hazard Ratio Interpretation for Clinicians → Mixed-effects model Used in 11% of respiratory trials · Linear Mixed Effects Models for Longitudinal Data → Odds ratio Used in 10% of respiratory trials · Effect Size Measures in Clinical Research → Non-inferiority trial design Used in 9% of respiratory trials · Non-Inferiority Trial Design Principles → Cox proportional-hazards model Used in 9% of respiratory trials · Cox Proportional Hazards: Model Diagnostics → Logistic regression Used in 7% of respiratory trials · Logistic Regression Part 2: A Worked Clinical Example → Risk difference Used in 6% of respiratory trials · Effect Size Measures in Clinical Research →

All respiratory trials

625 results

← All therapeutic areas